General Information of the Compound
Compound ID
CP0473633
Compound Name
4-bromo-2-(3-hydroxypropyl)-5-[4-[(2-methylphenyl)methyl]piperazin-1-yl]pyridazin-3-one
    Show/Hide
Structure
Formula
C19H25BrN4O2
Molecular Weight
421.339
Canonical SMILES
Cc1ccccc1CN1CCN(CC1)c1cnn(CCCO)c(=O)c1Br
    Show/Hide
InChI
InChI=1S/C19H25BrN4O2/c1-15-5-2-3-6-16(15)14-22-8-10-23(11-9-22)17-13-21-24(7-4-12-25)19(26)18(17)20/h2-3,5-6,13,25H,4,7-12,14H2,1H3
    Show/Hide
InChIKey
FKJWTWUZUHEYSG-UHFFFAOYSA-N
Physicochemical Property
logP
2.01882
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
61.6
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155519644
ChEMBL ID
CHEMBL4448384
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS